Filing a late 10q will cost them nearly $10k. They need that patent that nobody knows if they’re in clinical trials to sell or partner. Just seems like a stretch. Most bios fail and nobody is buying their products. Last 10q explains this.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.